StonvexLoading…
StonvexStonvexStonvexCore line items from EDBL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.34M | $12.81M | $8.68M | $5.86M |
Operating Income | $-6.68M | $-15.80M | $-10.08M | $-6.52M |
Net Income | $-3.67M | $-17.33M | $-21.25M | $-7.37M |
EPS (Diluted) | $-5.25 | $-117.64 | $9.95 | $-9.95 |
Total Assets | $17.48M | $20.60M | $20.13M | $21.81M |
Total Liabilities | $8.65M | $8.10M | $7.21M | $5.22M |
Cash & Equivalents | $1.95M | $1.11M | $828.00K | $2.82M |
Free Cash Flow OCF − CapEx | $147.00K | $-12.44M | $-9.68M | $-6.90M |
Shares Outstanding | 1.57M | 539.42K | 3.08M | 2.83M |